| Abstrakt: |
A recent study conducted by the INCLIVA Health Research Institute in Valencia, Spain, explores the potential of Torque Teno Virus (TTV) DNA load in blood as a biomarker for immunosuppression in hematological patients. The research suggests that high or increasing TTV DNA levels in the blood may indicate a higher risk of infectious complications in solid organ transplant recipients, while lower levels may anticipate the development of acute rejection. However, the study also highlights the need for further research, as contradictory data and poorly defined clinical outcomes have been reported in this area. Prospective, multicenter studies with well-defined clinical outcomes are necessary to determine the clinical value of TTV DNA load monitoring in the management of hematological patients. [Extracted from the article] |
